| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/03/2011 | US20110053995 Benzenesulfonanilide compound inhibitors of urea transporters |
| 03/03/2011 | US20110053993 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053980 Indane-amine derivatives, their preparation and use as medicaments |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053962 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 03/03/2011 | US20110053961 Substituted xanthine derivatives |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 03/03/2011 | US20110053927 Nanoparticle formation via rapid precipitation |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053868 L-sugar colon cleansing agent and uses thereof |
| 03/03/2011 | US20110053867 L-sugar colon cleansing agent and uses thereof |
| 03/03/2011 | US20110053260 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 03/03/2011 | US20110053259 Recombinant poxvirus expressing homologous genes inserted into the poxvirus genome |
| 03/03/2011 | US20110052733 Herbal compositions for the treatment of mucosal lesions |
| 03/03/2011 | US20110052711 Controlled release multidrug formulations for spinal cord injury |
| 03/03/2011 | US20110052707 Combination of vitamin d and 25-hydroxyvitamin d 3 |
| 03/03/2011 | US20110052706 Pancreatine pellets and method of producing same |
| 03/03/2011 | US20110052700 Gastric retentive pharmaceutical compositions for immediate and extended release of levosulpiride |
| 03/03/2011 | US20110052695 Drug delivery platforms comprising silk fibroin hydrogels and uses thereof |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052669 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 03/03/2011 | US20110052661 Pet dental hygiene product |
| 03/03/2011 | US20110052644 Composition comprising extract of cinnamomum cassia bark for improving normal flora and enhancing immune response |
| 03/03/2011 | US20110052623 Dried microbial cells or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine and method for production of the dried microorganism cell or microorganism extract |
| 03/03/2011 | US20110052615 Tumour-specific animal proteins |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052603 method of treatment and agents useful for same |
| 03/03/2011 | US20110052597 Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof |
| 03/03/2011 | US20110052560 Method for Increasing the Activity of the Immune System of a Mammal at Risk of Inflammatory Diseases |
| 03/03/2011 | US20110052557 Phytocomposition having antimicrobial activity |
| 03/03/2011 | US20110052538 Probiotic/non-probiotic combinations |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | US20110052519 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 03/03/2011 | US20110052496 Hollow nanoparticles and uses thereof |
| 03/03/2011 | DE102010031263A1 Agent, useful e.g. for treating body parts, plaque, halitosis, gingivitis, periodontal disease, wrinkles, age spots and inflammation, and for relieving irritation, comprises zucchini, Ananas, ginger, papaya and/or their extracts |
| 03/03/2011 | CA2790390A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | CA2772163A1 Bifidobacterium longum and functional gi disorders |
| 03/03/2011 | CA2769751A1 Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry |
| 03/02/2011 | EP2289970A1 Biocompatible polymers, their process of manufacture and compositions containing them |
| 03/02/2011 | EP2289941A2 Administration of agents for the treatment of inflammation |
| 03/02/2011 | EP2289894A2 Pyrrolo-triazine compounds useful as kinase inhibitors |
| 03/02/2011 | EP2289883A1 Novel FXR (NR1H4) binding and activity modulating compounds |
| 03/02/2011 | EP2289868A1 Carboxylic acid compound |
| 03/02/2011 | EP2289551A1 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2289527A1 Bifidobacterium longum and functional GI disorders |
| 03/02/2011 | EP2289522A1 Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
| 03/02/2011 | EP2289518A1 Therapeutic agent for inflammatory bowel disease |
| 03/02/2011 | EP2289509A2 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 03/02/2011 | EP2289505A1 Nutritional composition and food supplement containing such a nutritional composition. |
| 03/02/2011 | EP2289499A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 03/02/2011 | EP2288356A1 Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation |
| 03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |
| 03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
| 03/02/2011 | CN201752501U Shenchai Gankang soft capsule |
| 03/02/2011 | CN101983207A Anti mif antibodies |
| 03/02/2011 | CN101983188A Indolinone compound |
| 03/02/2011 | CN101982471A Technological process for extracting aucubin from fruits of eucommia ulmoides oliver |
| 03/02/2011 | CN101982200A Rhizoma coptidis total alkaloids resin complexes, sustained-release preparation thereof and preparation method thereof |
| 03/02/2011 | CN101982199A Compositions containing acid-unstable physiologically active compounds and process for producing the same |
| 03/02/2011 | CN101982184A Preparation method of taraxacum extract |
| 03/02/2011 | CN101518499B Light-cured composite resin for oral cavity by using single crystal diamond as filler and preparation method thereof |
| 03/02/2011 | CN101385827B Sea cucumber health paste and production method thereof |
| 03/02/2011 | CN101104604B Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 03/01/2011 | US7897842 GnTIII expression in plants |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/01/2011 | US7897614 Preventive agent/remedial agent for constipation predominant IBS |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 02/24/2011 | WO2011022449A1 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021524A1 Peptides inducing adhesive property of lactic acid bacterium and use of same |
| 02/24/2011 | WO2011021508A1 Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c |
| 02/24/2011 | WO2011020853A1 Compositions containing mixtures of fermentable fibers |
| 02/24/2011 | WO2011020615A1 Novel fxr (nr1h4 ) binding and activity modulating compounds |
| 02/24/2011 | WO2010147742A9 Use of nitrite salts in treating tissue damage |
| 02/24/2011 | WO2010123930A3 Chemosensory receptor ligand-based therapies |
| 02/24/2011 | WO2010121128A3 Compositions and methods for treating or inhibiting liver injury |
| 02/24/2011 | WO2010118286A3 Benzimidazole modulators of h1 receptor and/or ns4b protein activity |
| 02/24/2011 | WO2010111443A3 Omentum as a source of stromal/stem cells and medical treatments using omentum stromal/stem cells |
| 02/24/2011 | WO2010104309A9 Compositions for preventing or improving gastrointestinal diseases |
| 02/24/2011 | WO2010031521A3 Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders |
| 02/24/2011 | WO2008130863A3 Substituted benzimidazoles |